Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) EBITDA Margin (2024 - 2025)

Carlsmed (CARL) has disclosed EBITDA Margin for 2 consecutive years, with 69.11% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin rose 4891.0% year-over-year to 69.11%, compared with a TTM value of 84.29% through Dec 2025, changed N/A, and an annual FY2025 reading of 58.67%, up 3063.0% over the prior year.
  • EBITDA Margin was 69.11% for Q3 2025 at Carlsmed, down from 56.0% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 1931.38% in Q2 2024 and bottomed at 118.01% in Q3 2024.